Shree Ganesh Remedies P/B Ratio

Current P/B Ratio
5.15
High Valuation
Very High - Significant premium, high growth expectations or speculative

Shree Ganesh Remedies (SGRL) P/B ratio is 5.15 (High), book value per share ₹125.38 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Shree Ganesh Remedies share price chart.

Current Valuation Metrics

P/B Ratio 5.15
Current Price ₹648.25
Book Value/Share ₹125.38
Exchange BSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹163 Cr
Share Capital ₹13 Cr
Reserves & Surplus ₹150 Cr
Outstanding Shares 13,000,000
Book Value per Share ₹125.38

Valuation Signal

Signal Overvalued
Historical Avg 4.1
Historical Range 1.51 - 6.76
Percentile 60.0%

Sector Context

Sector Average -0.33
Sector Median 0.63
Sector Rank #11 of 50
Sector Percentile 22.0%

SGRL P/B Ratio — Valuation Insights & Book Value Analysis

Shree Ganesh Remedies price-to-book ratio interpretation, valuation status and historical context — current P/B 5.15 (High). View SGRL 52-week performance for the annual high/low range and current price position.

  • Stock appears overvalued with PB of 5.15, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 25.5% above historical average
  • Trading at premium to sector average PB of -0.33

Shree Ganesh Remedies P/B Ratio Historical Trend

SGRL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with SGRL DCF valuation to assess whether the stock is under or overvalued.

SGRL Historical P/B Ratio — Book Value Per Share & Year-End Price

Shree Ganesh Remedies annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 5.17 ₹125.38 ₹648.25 ₹163 High
2025 4.15 ₹111.54 ₹463.20 ₹145 High
2024 6.76 ₹93.85 ₹634.80 ₹122 High
2020 2.92 ₹46.67 ₹136.45 ₹42 Moderate
2019 1.51 ₹37.78 ₹56.90 ₹34 Moderate

SGRL vs Healthcare Peers — P/B Ratio Comparison

Shree Ganesh Remedies P/B 5.15 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.

Sector Average
-0.33
Sector Median
0.63
Lowest P/B
-17.92
Highest P/B
1.01
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.92 ₹22 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Parmax Pharma PARMAX -2.48 ₹14 Low
Bharat Immunologicals BIBCL -2.32 ₹76 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹127 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.63 ₹53 Low